ArticleMolecular biology of the cell2025
Domain-specific N-glycosylation of the adhesion G-protein-coupled receptor ADGRG6 N-terminal fragment regulates trafficking, proteolytic processing, and signaling.
Article in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adhesion G protein-coupled receptors.Pharmacological reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adhesion G-protein-coupled receptors (aGPCRs) are characterized by long extracellular N-terminus fragments (NTF) with several adhesive domains. Many aGPCRs are cleaved at the GPCR-autoproteolysis site (GPS), enclosed within the larger GPCR-autoproteolysis-inducing (GAIN) domain. Following cleavage at the endoplasmic reticulum (ER), the NTF and C-terminal fragments (CTF) heterodimerize, and the protomer is trafficked to the plasma membrane. ADGRG6 is an aGPCR playing important roles in embryonic development. It is activated by mechanical perturbation of the NTF and several extracellular matrix (ECM) proteins. GPCRs are known to undergo several posttranslational modifications (PTM) that regulate the molecular pharmacology of these receptors. N-glycosylation is an important PTM that regulates GPCR expression, trafficking, ligand binding, and signaling bias. Although ADGRG6 is N-glycosylated, the location of the glycans remains unknown. Furthermore, are there spatial roles of N-glycosylation in ADGRG6 processing, trafficking, and signaling? To address these gaps in knowledge, we used biochemical and cell-biological approaches using cell lines overexpressing wild-type and N-glycosylation mutants of ADGRG6. We demonstrate that specific N-glycan residues in different domains of the NTF of ADGRG6 have distinct roles in ADGRG6 autoproteolysis, furin cleavage, trafficking to the plasma membrane, and cAMP production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.